Uncategorised - European Medical Journal

Pharma in the UK

In 2021, the UK was named the sixth biggest pharmaceutical market, but it’s facing challenges to further growth. Read to find out more.

Is Obesity Linked to Hepatic Steatosis in Type 1 Diabetes?

According to new data, most adults with Type 1 diabetes who are overweight or obese develop non-alcoholic fatty liver disease. Read more…

Do Smaller Liver Transplant Candidates Wait Longer?

Waitlists for candidates with a smaller body surface area are significantly less likely to receive a liver transplant, according to research…

Dr Zsuzsanna Devecseri

Access to oncology treatments, diversity and lessons in leadership

The GOLD team are joined by Dr Zsuzsanna Devecseri, Vice President and Head of Global Oncology Medical, Sanofi Genzyme, to discuss her career journey and varied experience within the pharmaceutical industry.

Widal Positivity: Tuberculosis Diagnosis and Fluoroquinolone Resistance

Drug resistance among patients with tuberculosis (TB) is an emergent topic that requires intervention. According to a survey of TB drug resistance in India, resistance to any fluoroquinolones (FQ) reported in cases of multidrug resistance (MDR) to TB was 21.82%.

Advancing diversity in clinical trials

This infographic explores the diversity of patient populations in US clinical trials and the pharmaceutical industry’s efforts to address this and improve outcomes.

Does Sleep Duration Affect Vaccine Response?

Sleeping for less than 6 hours a night is associated with lower antibody responses after vaccinating for influenza and hepatitis. Read more!

Clot Risk Low for Outpatients with COVID-19

Patients with thrombophilia, those who have experienced VTE in the past and those of older age who get COVID-19 are at higher risk of VTE.

Interview: Hannah Gower

Hannah Gower | Cardiology and Internal Medicine Speciality Registrar, Royal Cornwall Hospitals NHS Trust, UK

Skin Phenotype Similarities in East African and African American Patients

Breaking data outlines the uniquities in the atopic dermatitis molecular phenotype among patients from African and African American ethnicities.